Idea AG Concludes Licence Agreement for Its Innovative Targeted Analgesic, Diractin, With Alpharma

September 6, 2007

IDEA AG announced that it has agreed with an affiliate of Alpharma Inc., to license the exclusive U.S. rights to Diractin (ketoprofen in Transfersome, formerly known as IDEA-033) as a prescription topical NSAID (non-steroidal anti-inflammatory drug) in the U.S.
Idea AG